Chenglin Jia

662 citations
27 papers · 505 indexed · h-index 12
Topics
MicroRNA in disease regulation (4 papers)Diabetic Foot Ulcer Assessment and Management (4 papers)Natural product bioactivities and synthesis (3 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEBiochemical and Biophysical Research Communications
Partner nations
ChinaUnited States

In The Last Decade

Chenglin Jia

24 papers receiving 501 citations

Peers

Chenglin Jia
Comparison fields: 5 of 101
  • Molecular Biology 229
  • Cancer Research 95
  • Pharmacology 55
  • Pharmacology 55
  • Epidemiology 54
Replace Yulong Tao with:
Yulong Tao China
Zhenxing Wang China
Chen‐Chen Sun China
Xiaoting Mo China
Huimin Zhu China
Demei Huang China
Zhiying Lin China
Caixia Pei China
Chenglin Jia relative to Yulong Tao China Yulong Tao's profile →
Citations per field
00.5×10×20×31×
Yulong Tao · 1×
Citations per year

Countries citing papers authored by Chenglin Jia

Since Specialization
Citations

This map shows the geographic impact of Chenglin Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglin Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglin Jia more than expected).

Fields of papers citing papers by Chenglin Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenglin Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglin Jia. The network helps show where Chenglin Jia may publish in the future.

Co-authorship network of co-authors of Chenglin Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Chenglin Jia. A scholar is included among the top collaborators of Chenglin Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglin Jia. Chenglin Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 0
4 0
5 0
6 6
7 4
8 1
9 7
10 25
11 3
12 31
13 43
14 1
15 51
16 23
17 15
18 29
19 77
20 70

About Chenglin Jia

Chenglin Jia is a scholar working on Pharmacology, Biological Psychiatry and Complementary and alternative medicine, having authored 27 papers that have together received 505 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Diabetic Foot Ulcer Assessment and Management (4 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Cancer Research (95 citations), Pharmacology (55 citations) and Complementary and alternative medicine (49 citations). Chenglin Jia has collaborated with scholars based in China and United States. Frequent co-authors include Minqi Xiong, Qinbo Yang, Peiwei Wang, Jingang Cui, Teng Zhang, Wenjian Wang, Xiaoye Du, Wenjian Wang, Yu Chen and Qingyu Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026